Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Keller Rohrback L.L.P. Announces Investigation of Pfizer Smoking Cessation Drug Chantix
Keller Rohrback L.L.P. Announces Investigation of Pfizer Smoking Cessation Drug Chantix
Keller Rohrback L.L.P. Announces Investigation of Pfizer Smoking Cessation Drug Chantix
Submitted by
admin
on May 28, 2011 - 12:17pm
Source:
Yahoo/BusinessWire
News Tags:
Pfizer
smoking cessation
Chantix
Headline:
Keller Rohrback L.L.P. Announces Investigation of Pfizer Smoking Cessation Drug Chantix
Do Not Allow Advertisers to Use My Personal information